Actavis Announces Acanya® Gel Patent Challenge Settlement

[PR Newswire] – DUBLIN, May 12, 2014 /PRNewswire/ — Actavis plc (ACT) today announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent litigation related to Actavis’ generic version of Aca more

View todays social media effects on ACT

View the latest stocks trending across Twitter. Click to view dashboard

See who Actavis is hiring next, click here to view